<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02501733</url>
  </required_header>
  <id_info>
    <org_study_id>121416-01</org_study_id>
    <nct_id>NCT02501733</nct_id>
  </id_info>
  <brief_title>Medacta GMK Sphere® Multicenter Post-Market Outcomes Study</brief_title>
  <official_title>Medacta GMK Sphere® Medial Pivot, Cruciate Substituting Multicenter, Post-Market Outcomes Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta USA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to average Forgotten Knee Score (FJS) of those patients receiving the Medacta
      GMK Sphere® knee at the two and five year time points. 70 subjects, enrolled at the data
      coordinating center in Medacta GMK Sphere® vs Posterior Stabilized study (WIRB Pro Num:
      20141994) and randomized to the Sphere arm, will have their data utilized for this study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the change in Forgotten Knee Scores (FJS) of those patients receiving the Medacta GMK Sphere from baseline to years 2 and 5 post-operatively.</measure>
    <time_frame>Baseline, 2 and 5 year time points</time_frame>
    <description>Knee function-patients ability to forget the artificial joint in everyday life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Knee Society Score (KSS)</measure>
    <time_frame>Pre-operative, 6 weeks, 3-6 months, 1,2,3,4 and 5 years.</time_frame>
    <description>Total Knee Society score questionnaire to assess pain and function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Krackow Activity Scale (KAS)</measure>
    <time_frame>Pre-operative, 6 weeks, 3-6 months, 1,2,3,4 and 5 years</time_frame>
    <description>The Krackow Activity Scale (KAS) lower extremity activity scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Analysis</measure>
    <time_frame>Pre-operative, 6 weeks, 3-6 months, 1,2,3,4 and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AP long standing X-ray</measure>
    <time_frame>Pre-operative and 6 weeks</time_frame>
    <description>Determine degree of Varus or Valgus</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Medacta GMK Sphere® Knee Prosthesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects enrolled will receive the Medacta GMK Sphere® Medial Knee Prosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta GMK Sphere® Medial Knee Prosthesis</intervention_name>
    <description>There is no consensus within the Arthroplasty community as to whether a traditional post and cam-style Posterior Stabilized total knee device is superior to a medial-pivot, more congruent device. However, the majority of surgeons seem to prefer the former, though there is a minority that uses the latter device with great success.
To date, there have been few prospective trials directly comparing these devices, and none with the latest generation of Total Knee Arthroplasty implants. Almost all such studies have been retrospective and/or utilizing older generation devices.</description>
    <arm_group_label>Medacta GMK Sphere® Knee Prosthesis</arm_group_label>
    <other_name>Total Knee Arthroplasty</other_name>
    <other_name>Total Knee Prosthesis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients willing to sign the informed consent

          -  Patients able to comply with follow-up requirements including postoperative weight
             bearing restrictions and self evaluations.

          -  Male and non-pregnant female patients ages 21 - 80 years of age at the time of
             surgery.

          -  Patients requiring a primary total knee replacement.

          -  Patients with a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or
             avascular necrosis (AVN).

          -  Patients with intact collateral ligaments.

        Exclusion Criteria:

          -  Patients with inflammatory arthritis.

          -  Patients that are morbidly obese, body mass index (BMI) &gt; 40.

          -  Patients with a history of total or unicompartmental reconstruction of the affected
             joint.

          -  Patients that have had a high tibial osteotomy or femoral osteotomy.

          -  Patients with neuromuscular or neurosensory deficiency, which would limit the ability
             to assess the performance of the device.

          -  Patients with a systemic or metabolic disorder leading to progressive bone
             deterioration.

          -  Patients that are immunologically compromised, or receiving chronic steroids (&gt; 30
             days).

          -  Patients bone stock is compromised by disease or infection, which cannot provide
             adequate support and/or fixation to the prosthesis.

          -  Patients with knee fusion to the affected joint.

          -  Patients with an active or suspected latent infection in or about the knee joint.

          -  Patients that are prisoners.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mukesh Ahuja, MBBS, MS</last_name>
    <role>Study Director</role>
    <affiliation>Medacta USA, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mukesh Ahuja, MBBS, MS</last_name>
    <phone>312-548-9968</phone>
    <email>Mahuja@medacta.us.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Norhtwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Manning, MD</last_name>
      <phone>312-695-1441</phone>
      <email>dmanning@nmff.org</email>
    </contact>
    <contact_backup>
      <last_name>Matthew Beal, MD</last_name>
      <phone>312-926-4444</phone>
      <email>mbeal@nmff.org</email>
    </contact_backup>
    <investigator>
      <last_name>David Manning, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Beal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Institute for Hip and Knee Surgery</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78751</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Dodgin, MD</last_name>
      <phone>512-476-2830</phone>
      <email>ddodgin@orthoaustin.com</email>
    </contact>
    <investigator>
      <last_name>David Dodgin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Orthopedics</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78759</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tyler Goldberg, MD</last_name>
      <phone>512-439-1001</phone>
      <email>tgoldberg@texasorthopedics.com</email>
    </contact>
    <investigator>
      <last_name>Tyler Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spokane Joint Replacement Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Scott, MD</last_name>
      <phone>509-466-6393</phone>
      <email>dfscott@orthospecialtyclinic.com</email>
    </contact>
    <investigator>
      <last_name>David F Scott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2015</study_first_submitted>
  <study_first_submitted_qc>July 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2015</study_first_posted>
  <last_update_submitted>October 17, 2017</last_update_submitted>
  <last_update_submitted_qc>October 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total Knee Replacement</keyword>
  <keyword>Total Knee Arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

